when is semaglutide off patent 50+ Branded Generics To Enter India As Diabetes Drug Expires In March 2026 Looming GLP-1 drug patent expirations
Description
2014;9(8) doi: 10.1371/journal.pone.0101978
Clinical evidence supports this approach: patients who continue GLP-1 therapy at reduced doses maintain 7580% of their weight loss over 2+ years
Your specific health goals are paramount
Ask your provider to review your records to make sure everything that supports your need for the medication is clearly documented, says Small
No meaningful clinical difference in safety or efficacy
